Phase II trial of fotemustine in patients with metastatic malignant melanoma.

Saved in:
Bibliographic Details
Title: Phase II trial of fotemustine in patients with metastatic malignant melanoma.
Authors: Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson G, Falkson HC
Source: Investigational new drugs [Invest New Drugs] 1994; Vol. 12 (3), pp. 251-4.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0167-6997
DOI:10.1007/BF00873967